Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2233
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRamesh, Thippani-
dc.contributor.authorNageswara Rao, Pothuraju-
dc.contributor.authorNageswara Rao, Ramisetti-
dc.date.accessioned2024-12-30T10:02:44Z-
dc.date.available2024-12-30T10:02:44Z-
dc.date.issued2014-
dc.identifier.citation10.1016/j.jpba.2013.10.018en_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2233-
dc.descriptionNITWen_US
dc.description.abstractA rapid, specific and reliable isocratic LC–MS/MS method has been developed and validated for the identification and characterization of stressed degradation products of Zofenopril. Zofenopril, an antihypertensive drug, was subjected to hydrolysis (acidic, alkaline and neutral), oxidation, photolysis and thermal stress, as per ICH-specified conditions. The drug showed extensive degradation under oxidative and base hydrolysis stress conditions. However, it was stable to thermal, acid, neutral and photolysis stress conditions. A total of 6 degradation products were observed and the chromatographic separation of the drug and its degradation products were achieved on Phenomenex (Luna) C18 (250 mm × 4.6 mm, i.d., 5 m) column using 20 mM ammonium acetate: acetonitrile (50:50, v/v) as a mobile phase. The degradation products were characterized by LC–MS/MS and its fragmentation pathways were proposed. The LC–MS method was validated with respect to specificity, linearity, accuracy and precisien_US
dc.language.isoenen_US
dc.publisherJournal of Pharmaceutical and Biomedical Analysisen_US
dc.subjectZofenoprilen_US
dc.subjectForced degradationen_US
dc.titleLC–MS/MS characterization of forced degradation products of zofenoprilen_US
dc.typeArticleen_US
Appears in Collections:Chemistry

Files in This Item:
File Description SizeFormat 
LC–MS_MS characterization of forced degradation products of zofenopril.pdf1.17 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.